• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Jean Waters, UK

    Jean Waters, UK

  • John Russo, USA

    John Russo, USA
    final3878

  • Anita Forte, USA

    Anita Forte, USA

  • Susan Keldani, USA

    Susan Keldani, USA

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Len Johnrose, England

    Len Johnrose, England

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • John Dinon, Australia

    John Dinon, Australia

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • David Hall, USA

    David Hall, USA

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • David Watson, Scotland

    David Watson, Scotland

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Jon Newsome, USA

    Jon Newsome, USA

  • Paul Launer, USA

    Paul Launer, USA

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Luis Antonio Pimenta Lima, Brazil

    Luis Antonio Pimenta Lima, Brazil

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Mark Miller, UK

    Mark Miller, UK

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Jay Epstein, USA

    Jay Epstein, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login